Lv5
1028 积分 2023-12-04 加入
Poster Session 2
1个月前
已完结
2024 ACCP Virtual Poster Symposium May 21 ‐ 22, 2024
1个月前
已完结
CLINICAL CHARACTERISTICS OF EARLY ADOPTERS OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 INHIBITORS (PCSK9I)
1个月前
已完结
Cholesterol-lowering therapy in patients with symptomatic peripheral arterial disease – real life data in a German population
1个月前
已完结
LDL cholesterol in patients with peripheral artery disease: A real world registry
1个月前
已完结
Markers of optimal medical therapy are associated with improved limb outcomes after elective revascularization for intermittent claudication
1个月前
已完结
Effectiveness of Blood Lipid Management in Patients With Peripheral Artery Disease
1个月前
已完结
The addition of evolocumab to maximal tolerated statin therapy improves walking performance in patients with peripheral arterial disease and intermittent claudication (Evol-PAD study)
1个月前
已完结
Antithrombotic and Lipid Lowering Therapy is Associated With Improved Survival After Vascular Surgery: A Population Based Study From Norway
1个月前
已完结
Effect of Comorbidities on Outcomes of Infrapopliteal Angioplasty in Patients with Chronic Limb-Threatening Ischemia
1个月前
已完结
皖公网安备34019202002308
